missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ PODXL2 Polyclonal Antibody

Description
In direct ELISAs and Western blots, less than 5% cross-reactivity with recombinant human PODXL. Reconstitute at 0.2 mg/mL in sterile PBS. Endoxin level is <0.10 EU per 1 μg of the antibody by the LAL method.
Podolyxin is a CD34 family member expressed by podocytes, vascular endothelium, mesothelium, and a subset of hematopoietic progenitors. It is the major sialoprotein in the glycocalyx of glomerular podocytes. The physiologic role of podolyxin in leukemic blasts is unknown. However, it is thought of as a candidate prostate cancer tumor aggressiveness gene. Podolyxin appears to complement CD34 as a useful cell surface marker for hemangioblasts, the common precursors of hematopoietic and endothelial cells.
Specifications
Specifications
| Antigen | PODXL2 |
| Applications | Flow Cytometry, Western Blot, Immunocytochemistry |
| Classification | Polyclonal |
| Concentration | 0.2 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 5% trehalose and No Preservative |
| Gene | PODXL2 |
| Gene Accession No. | Q9NZ53 |
| Gene Alias | D130074J02Rik; EG; endoglycan; LOW QUALITY PROTEIN: podocalyxin-like protein 2; PODLX2; podocalyxin like 2; podocalyxin-like 2; podocalyxin-like protein 2; Podxl2; RGD1305815; sialomucin protein; UNQ1861/PRO3742 |
| Gene Symbols | PODXL2 |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?